Skip to main content
News

Researchers awarded major funding for development and commercialization of noninvasive diagnostic test for inflammatory bowel disease

15.1.20246 toukokuun, 2024

Researchers awarded major funding for development and commercialization of noninvasive diagnostic test for inflammatory bowel disease

https://www.abo.fi/en/news/researchers-awarded-major-funding-for-development-and-commercialization-of-noninvasive-diagnostic-test-for-inflammatory-bowel-disease/

Contact Us

Please enable JavaScript in your browser to complete this form.

Feanalytic develops new non-invasive diagnostic assays to detect and monitor IBD and its subtypes. New diagnostic tools will improve IBD diagnosis and treatment planning.

Meet The Team

Mail Us

Åbo Akademi University / Biocity
Cell Biology
Tykistökatu 6
FI-20520 Turku
Finland

feanalytic.finland@gmail.com